NCT00100984终止4 期
A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 8
- 试验地点
- 20
研究概览
简要总结
The main objective of this study is to compare the safety and efficacy of an enfuvirtide containing regimen to a nucleoside combination regimen. Resistance information will also be collected.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •CD4 cell count greater than 50 cells/mm^3
- •HIV-1 RNA viral load greater than or equal to 5000 copies/mL
- •Patients must be HIV treatment experienced
- •Patients diagnosed with HIV-1 infection
排除标准
- •Female patients must not be able to have children or must be under effective contraceptives
- •Female patients who are pregnant
- •Have taken enfuvirtide and/or T-1249 before
- •Have serious kidney problems
- •Alcohol and/or drug abuse
- •Have had an organ transplant
研究者
研究点 (20)
Loading locations...
相似试验
已完成
4 期
Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected PatientsHIV InfectionsNCT00002229Hoffmann-La Roche80
已完成
3 期
A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney DiseaseAIDS-Associated NephropathyHIV InfectionsNCT00002397Hoffmann-La Roche24
已完成
2 期
A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenHIV InfectionsNCT00000913National Institute of Allergy and Infectious Diseases (NIAID)50
已完成
1 期
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their NewbornsPregnancyHIV InfectionsNCT00000920National Institute of Allergy and Infectious Diseases (NIAID)24
已完成
2 期
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral DrugsHIV InfectionsNCT00002162Hoffmann-La Roche140